# Prospective arm-volume surveillance to catch and reverse lymphoedema early

Source: https://onco.cc/ideas/idea-acc-lymphoedema-prospective-surveillance/  
OnCo record `idea-acc-lymphoedema-prospective-surveillance` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Arm swelling after breast cancer surgery is common and lifelong once established, but if caught early with simple measurements and treated with a sleeve, most cases can be prevented from becoming permanent.

## Summary

Breast cancer-related lymphoedema affects a large minority of patients who have axillary surgery or radiotherapy. Prospective surveillance with bioimpedance spectroscopy or arm-volume measurement, and early compression when subclinical change is detected, reduced progression to chronic lymphoedema substantially in a randomised trial (PREVENT). Surveillance is rarely implemented. Making it a standard component of breast cancer follow-up is inexpensive.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Routine prospective surveillance with early intervention will reduce the incidence of chronic lymphoedema at three years by at least half compared with symptom-triggered management.
- Rationale: Randomised evidence exists; the intervention is cheap and the condition is otherwise irreversible, so implementation is the whole problem.
- Proposed test: A stepped-wedge implementation across breast units with chronic lymphoedema incidence, quality of life, and cost as endpoints.
- Maturity: being-tested-at-scale
- Actor: clinic

## Sources

- Bottleneck evidence (Survivorship and late effects are neglected): NCI Office of Cancer Survivorship statistics: https://cancercontrol.cancer.gov/ocs/statistics

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Recovery & Rejuvenation](https://onco.cc/fronts/rejuvenation/), [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- bottlenecks: [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/), [Toxicity and quality of life are undervalued](https://onco.cc/bottlenecks/b-toxicity-qol/)
- technologies: [Lymphoedema: catching it early, and the operations for it](https://onco.cc/technologies/lymphoedema-surgery-and-early-detection/)
- roadmaps: [Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards](https://onco.cc/roadmaps/survivorship-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-acc-lymphoedema-prospective-surveillance.json